Difference between revisions of "Medical Reporting/Vaccine and Treatment News"
Jump to navigation
Jump to search
(→Treatment Options) |
(→Treatment Options) |
||
| Line 8: | Line 8: | ||
===Treatment Options=== | ===Treatment Options=== | ||
*03 APR 2020 [http://theconversation.com/a-small-trial-finds-that-hydroxychloroquine-is-not-effective-for-treating-coronavirus-135484?fbclid=IwAR06wB8LAEiuTDaGhLZGxMLa1EqIRlSxUZugBzEq29vkLWaFDyuRapl7HVw A small trial finds that hydroxychloroquine is not effective for treating coronavirus] | *03 APR 2020 [http://theconversation.com/a-small-trial-finds-that-hydroxychloroquine-is-not-effective-for-treating-coronavirus-135484?fbclid=IwAR06wB8LAEiuTDaGhLZGxMLa1EqIRlSxUZugBzEq29vkLWaFDyuRapl7HVw A small trial finds that hydroxychloroquine is not effective for treating coronavirus] | ||
| − | |||
| − | |||
* 25 MAR 2020 [https://www.ft.com/content/31de03b8-6dbc-11ea-89df-41bea055720b?fbclid=IwAR3r-VY54kKWv0bCmkuL-wu6B6WPdt4DkOWHHkmnw4qHdRg-qeBWeIV0EUQ Sweden bucks global trend with experimental virus strategy] | * 25 MAR 2020 [https://www.ft.com/content/31de03b8-6dbc-11ea-89df-41bea055720b?fbclid=IwAR3r-VY54kKWv0bCmkuL-wu6B6WPdt4DkOWHHkmnw4qHdRg-qeBWeIV0EUQ Sweden bucks global trend with experimental virus strategy] | ||
* 24 MAR 2020 [https://inside.mountsinai.org/blog/mount-sinai-to-begin-the-transfer-of-covid-19-antibodies-into-critically-ill-patients/?fbclid=IwAR2CcXcdOujkVZLtKMjLBDCKDk45lue7h6F7yTu9JO0UB87QtLSqF3-mQp8 Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients] - The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that the antibodies will neutralize it. | * 24 MAR 2020 [https://inside.mountsinai.org/blog/mount-sinai-to-begin-the-transfer-of-covid-19-antibodies-into-critically-ill-patients/?fbclid=IwAR2CcXcdOujkVZLtKMjLBDCKDk45lue7h6F7yTu9JO0UB87QtLSqF3-mQp8 Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients] - The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that the antibodies will neutralize it. | ||
Revision as of 01:08, 6 April 2020
Contents
Medical Reporting and Research
Minimal Requirement of being a verified major news outlet with a high unbiased rating on The Media Bias Chart and/or from reputable sources, such as research facilities and universities
Strong recommendation to not take action or make assumptions based upon research which may be dated, changing or part of ongoing research
Published for General Public Reading
Treatment Options
- 03 APR 2020 A small trial finds that hydroxychloroquine is not effective for treating coronavirus
- 25 MAR 2020 Sweden bucks global trend with experimental virus strategy
- 24 MAR 2020 Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients - The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that the antibodies will neutralize it.
- 22 MAR 2020 WHO launches global megatrial of the four most promising coronavirus treatments
Viral Research
- 8 strains of the coronavirus are circling the globe. Here's what clues they're giving scientists.
- Conclusions: Our findings suggest that patients with a shorter incubation period went on to have more severe disease. Further studies are needed to investigate potential biological mechanisms for this association.
- 27 MAR 2020 How sick will the coronavirus make you? The answer may be in your genes
Vaccine Research
Doctor's Note: Can you catch coronavirus twice?
Peer-Reviewed Research
- 00 SEP 2015 Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection
- 24 MAR 2020 Investigating Decontamination and Reuse of Respirators in Public Health Emergencies
- 10 MAR 2020 The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- 25 FEB 2020 Laboratory diagnosis of emerging human coronavirus infections – the state of the art
- 14 FEB 2020 Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study
- 06 FEB 2020 Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020
